Sign in
CompletedNo phase

Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for PTSD

Key facts

Who runs it
Neurovalens Ltd.
Where
San Diego, United StatesSee the site
Trial code
Status
Completed
People taking part
383 people enrolled
Started
13 Feb 2023
Ended
2 Dec 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Modius Spero active device
  • Sham device
Record updated
4 June 2025

Who can take part

Age
22 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 36 criteriaShow less

Who can take part

  • Signed informed consent
  • Diagnosed PTSD by a medical practitioner
  • Post-Traumatic Checklist (PCL-5) score or 31 or above
  • Eligibility confirmed via the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5)
  • Male or female, age ≥ 22 years and ≤ 80 years at the time of signing informed consent
  • Ability and willingness to complete all study visits and procedures, including completion of mental health questionnaires
  • Ability and willingness to adhere to 30 minutes usage of the device daily for the duration of the trial
  • Agreement not to start any new PTSD, mental health, or insomnia medications for the duration of the trial and/or to inform the study team if intending on starting any new PTSD, mental health, or insomnia medications
  • Agreement not to change any PTSD specific treatments for the duration of the trial e.g cognitive processing therapy
  • Agreement not to undergo any significant lifestyle changes that may affect sleep (e.g. excessive exercise, sleep interventions etc.) for the duration of the trial
  • Agreement not to use sleep trackers (e.g. Fitbit) for the duration of the trial
  • Agreement not to travel across different time zones for the duration of the trial
  • Access to Wi-Fi (for app to be able to upload usage data)
  • Access to computer, laptop, iPad or tablet (to conduct remote study visits and complete study questionnaires remotely)
  • Screening review by PTSD physician (study PI)
  • Willingness to download and use a video platform (e.g Zoom) to conduct remote study visits
  • Willingness to engage weekly with your Clinical Trial Mentor (CTM)

Who cannot take part

  • Taking H2-receptor antagonist medication
  • Previous use of Modius device
  • History of skin breakdown, eczema, or other dermatological condition (e.g., psoriasis) affecting the skin behind the ears
  • History of severe tinnitus or vertigo
  • History or presence of malignancy within the last year
  • History of chronic viral infection that causes vestibular neuropathy (e.g., hepatitis or HIV)
  • A history of stroke or severe head injury as defined by a head injury that required a craniotomy or endotracheal intubation (in case this damaged the neurological pathways involved in vestibular stimulation)
  • Diagnosis of epilepsy
  • Failure to agree to use of device daily during study participation
  • Any other medical condition, or medication use, that in the opinion of the PI is likely to make the subject refractory to VeNS
  • Use of beta-blockers within 1 month of starting the study
  • Use of antihistamines
  • Presence of permanently implanted battery powered medical device or stimulator (e.g., pacemaker, implanted defibrillator, deep brain stimulator, vagal nerve stimulator etc.)
  • Female who is pregnant, breast-feeding or intends to become pregnant or is of childbearing potential and not using an adequate contraceptive method
  • Diagnosis of active migraines
  • Participation in other research studies sponsored by Neurovalens
  • Participation in any other PTSD studies
  • Not fluent in English language
  • Have a member of the same household who is currently participating in this study

Where in United States

  • VA San Diego Healthcare SystemSan Diego, United States

About the trial

What the trial wants to find out

Trial title: A Randomized, Double Blind Sham Controlled Clinical Trial to Evaluate the Efficacy of Electrical Vestibular Nerve Stimulation (VeNS), Compared to a Sham Control for Treatment of PTSD

Read full original descriptionShow less

The aim of this study: To better evaluate the efficacy of non-invasive electrical vestibular nerve stimulation (VeNS) as a method of treating PTSD, as compared to a sham control.

Allocation: Randomized to either active device or control device usage.

Endpoint classification: Efficacy Study Intervention Model: Parallel Assignment in 1:1 active to control allocation

Sample size: The aim is to recruit a total of up to 400 participants. The study will last 12 weeks in total for each subject.

The 2 groups in the trial

  • Active VeNSExisting treatment, for comparison

    The active device utilizes a technology termed vestibular nerve stimulation (VeNS). The device will be placed on the head in a manner analogous to headphones and will deliver a small electrical current to the skin behind the ears, over the mastoid processes. Participants will be advised to use the device at home for 30 minutes per day.

    Treatment: Modius Spero active device

  • Sham VeNSSham treatment, for comparison

    The sham device looks identical to the active device and interacts with the app in a similar manner to the active device. It will apply some stimulation to a user for a limited period of time (30 seconds), before tapering down to zero over a further 20 seconds, thus creating the impression of an active device. The device will be placed on the head in a manner analogous to headphones with hydrogel electrodes placed over the mastoid processes. Participants will be advised to use the device at home for 30 minutes per day.

    Treatment: Sham device

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Randomized, Double Blind Sham Controlled Clinical Trial to Evaluate the Efficacy of Electrical Vestibular Nerve Stimulation (VeNS), Compared to a Sham Control for Treatment of Post- Traumatic Stress Disorder (PTSD)
Record updated
4 June 2025